Science Explorer Back to mapMap

Most cited papers from Royal Brompton Hospital

What are the most cited papers from Royal Brompton Hospital?

The most cited paper from Royal Brompton Hospital is "Mutations of the BRAF gene in human cancer" (Helen Ruth Davies et al., 2002), with 10,791 citations. Next come "An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management" (7,347) and "The 2015 World Health Organization Classification of Lung Tumors" (4,651).

Showing 50 of 60 papers. Every paper with more than 1,061 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mutations of the BRAF gene in human cancer Helen Ruth Davies et al. · Nature Jun 2002 10,791
2 An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Ganesh Raghu et al. · American Journal of Respiratory and Critical Care Medicine Open access Mar 2011 7,347
3 The 2015 World Health Organization Classification of Lung Tumors William David Travis, Elisabeth M. Brambilla, Andrew Gordon Nicholson et al. · Journal of Thoracic Oncology Open access 21 Aug 2015 4,651
4 Fleischner Society: Glossary of Terms for Thoracic Imaging David M. Hansell, Alexander A. Bankier, Heber MacMahon et al. · Radiology 14 Jan 2008 4,302
5 Updated Clinical Classification of Pulmonary Hypertension Gérald Simonneau, Michael Athanassios Gatzoulis, Ian Adatia et al. · Journal of the American College of Cardiology Open access Dec 2013 4,211
6 International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Kian Fan Chung et al. · European Respiratory Journal 12 Dec 2013 3,995
7 The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours Peter Goldstraw, John Crowley, Kari Chansky et al. · Journal of Thoracic Oncology Open access Aug 2007 3,691
8 Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome Gregory G. Schwartz et al. · New England Journal of Medicine Open access 7 Nov 2018 3,654
9 Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia Deepak L. Bhatt, Philippe Gabríel Steg, Michael J. Miller et al. · New England Journal of Medicine 10 Nov 2018 3,331
10 Patterns of somatic mutation in human cancer genomes Christopher D. Greenman et al. · Nature Open access Mar 2007 3,167
11 Effect of Carvedilol on Survival in Severe Chronic Heart Failure Milton Packer, Andrew J.S. Coats, Michael B. Fowler et al. · New England Journal of Medicine Open access 31 May 2001 3,110
12 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Behnood Bikdeli et al. · Journal of the American College of Cardiology Open access 17 Apr 2020 2,956
13 Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt et al. · New England Journal of Medicine Open access 12 Mar 2006 2,837
14 Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper Matthias G. Friedrich, Udo P Sechtem, Jeanette Schulz‐Menger et al. · Journal of the American College of Cardiology Open access Apr 2009 2,526
15 Initial Invasive or Conservative Strategy for Stable Coronary Disease David Joel Maron et al. · New England Journal of Medicine Open access 30 Mar 2020 2,464
16 Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Kim M. Fox · The Lancet Sep 2003 2,160
17 Acute Skeletal Muscle Wasting in Critical Illness Zudin Puthucheary et al. · JAMA Open access 9 Oct 2013 2,132
18 Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 Elizabeth A. Whittaker et al. · JAMA Open access 8 Jun 2020 2,062
19 Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction Marc P. Bonaca et al. · New England Journal of Medicine Open access 14 Mar 2015 2,003
20 Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents Laura Mauri et al. · New England Journal of Medicine Open access 16 Nov 2014 1,928
21 Lipid peroxidation and antioxidants as biomarkers of tissue damage John M.C. Gutteridge · Clinical Chemistry Dec 1995 1,847
22 Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study Michael Athanassios Gatzoulis, Seshadri Balaji, Steven A. Webber et al. · The Lancet Sep 2000 1,788
23 Heart Failure: Preventing Disease and Death Worldwide Piotr P. Ponikowski, Stefan D. Anker, Khalid F. AlHabib et al. · ESC Heart Failure Open access Sep 2014 1,717
24 Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Keith A.A. Fox, Omar H. Dabbous, Robert Joel Goldberg et al. · BMJ Open access 10 Oct 2006 1,704
25 Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload Lisa Anderson · European Heart Journal Dec 2001 1,687
26 Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine Open access 20 May 2019 1,667
27 International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology Jelena Rima Ghadri et al. · European Heart Journal Open access 17 Apr 2018 1,616
28 The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer Pieter E. Postmus, Elisabeth M. Brambilla, Kari Chansky et al. · Journal of Thoracic Oncology Open access Aug 2007 1,603
29 Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Marcus D Flather, Salim Yusuf, Lars Køber et al. · The Lancet May 2000 1,595
30 Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases Ugo Pastorino, Marc E Buyse, Godehard Friedel et al. · Journal of Thoracic and Cardiovascular Surgery Open access 1997 1,545
31 Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing Jeanette Schulz‐Menger, David A. Bluemke, Jens Bremerich et al. · Journal of Cardiovascular Magnetic Resonance Open access 2013 1,528
32 Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis Timothy David Warner, Francesco Giuliano, Ivana Vojnovic et al. · Proceedings of the National Academy of Sciences Open access 22 Jun 1999 1,516
33 Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine 14 Jun 2016 1,486
34 Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Frank Grothues, Gillian C. Smith, James Moon et al. · The American Journal of Cardiology Jul 2002 1,460
35 Increased nitric oxide in exhaled air of asthmatic patients Sergei A. Kharitonov, D. H. Yates, R A Robbins et al. · The Lancet 1994 1,444
36 Idiopathic pulmonary fibrosis Fernando J. Martínez, Harold R. Collard, Annie Pardo et al. · Nature Reviews Disease Primers Review 19 Oct 2017 1,412
37 European Respiratory Society guidelines for the management of adult bronchiectasis Eva Polverino et al. · European Respiratory Journal Open access Sep 2017 1,387
38 Guidelines on the management of stable angina pectoris: executive summary Authors/Task Force Members et al. · European Heart Journal 31 May 2006 1,346
39 Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I Mathew L. Coleman, Erik A. Sahai, Margaret Yeo et al. · Nature Cell Biology 6 Mar 2001 1,309
40 The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic Geoffrey D. Rubin et al. · CHEST Journal Open access 7 Apr 2020 1,306
41 COVID-19 cytokine storm: the interplay between inflammation and coagulation Ricardo Jorge Paixão José, Ari R. Manuel · The Lancet Respiratory Medicine Open access 27 Apr 2020 1,303
42 Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up John B.A.G. Haanen, Michel Obéid, Lavinia Anne Spain et al. · Annals of Oncology Open access 18 Oct 2022 1,285
43 Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology Alexander Richard Lyon, Eduardo Bossone, Birke Schneider et al. · European Journal of Heart Failure Open access 9 Nov 2015 1,223
44 Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases Pablo García‐Pavía et al. · European Heart Journal Open access 2 Feb 2021 1,221
45 The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer Valerie W. Rusch, Hisao Asamura, Hirokazu Watanabe et al. · Journal of Thoracic Oncology Open access May 2009 1,213
46 Interstitial Lung Disease in Systemic Sclerosis Nicole S L Goh, Sujal R. Desai, Srihari Veeraraghavan et al. · American Journal of Respiratory and Critical Care Medicine 27 Mar 2008 1,209
47 Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy Ankur Gulati et al. · JAMA 6 Mar 2013 1,193
48 Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis Luca Richeldi, Ulrich Costabel, Moisés Selman et al. · New England Journal of Medicine Open access 21 Sep 2011 1,178
49 Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy Ravi G. Assomull, Sanjay Kumar Prasad, Jonathan C. Lyne et al. · Journal of the American College of Cardiology Open access Nov 2006 1,169
50 Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement James Moon, Daniel Messroghli, Peter Kellman et al. · Journal of Cardiovascular Magnetic Resonance Open access 2013 1,161

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.